Why is BioInvent International AB ?
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of -23.13%, its profits have risen by 23.9%
- Along with generating -23.13% returns in the last 1 year, the stock has also underperformed OMX Stockholm 30 in the last 3 years, 1 year and 3 months
How much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is BioInvent International AB for you?
High Risk, Low Return
Quality key factors
Valuation Key Factors 
Technical key factors
Technical Movement
Highest at SEK -255.51 MM
Higher at SEK 201.42 MM
Higher at SEK -90.42 MM
Lowest at -99.52 %
Fallen by 0% (YoY
Highest at 4.9 times
Lowest at SEK 3.32 MM
Lowest at SEK -129.04 MM
Lowest at -3,885.61 %
Lowest at SEK -129.15 MM
Lowest at SEK -129.22 MM
Lowest at SEK -1.96
Here's what is working for BioInvent International AB
Debt-Equity Ratio
Operating Cash Flows (SEK MM)
Debtors Turnover Ratio
Raw Material Cost as a percentage of Sales
Here's what is not working for BioInvent International AB
Net Sales (SEK MM)
Pre-Tax Profit (SEK MM)
Net Profit (SEK MM)
Net Sales (SEK MM)
Operating Profit (SEK MM)
Operating Profit to Sales
Pre-Tax Profit (SEK MM)
Net Profit (SEK MM)
EPS (SEK)






